Skip to content

PLURIPHARM BELGIUM

Active
Private limited companyfounded 2024active for 2 yearsOudebaan 61, 2610 Antwerpen, BelgiumKBO/BCE: BE 1011.718.215
Summary

The computed 12-month bankruptcy probability of PLURIPHARM BELGIUM is 14.0% (high). The latest annual accounts of PLURIPHARM BELGIUM were filed more than 90 days after the deadline. The 2024 annual accounts show equity of €5,000. Its solvency ranks better than 95% of 15,452 sector peers (NACE 46, financial year 2024). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€5,000total assets 2024
Equity
€5,000
Turnover not published (micro format)
Financial health
Bankruptcy probabilitywithin 12 months
14.0%
Too few figures to score
Structure
Parent
TMF BELGIUM · 100%
2024 accounts filed 208 days late
Signalsraises risk1 financial year not filed after the legal deadline; last filed accounts filed 208 days late; 1 of the last 3 late1 change of registered office in 24 monthsFigures for financial year 2024 (filed 26-02-2026)Founded in 20242024 accounts filed 208 days lateShow the evidence

Bankruptcy probability

No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability.
Bankruptcy probability: High
Filing: Filed more than 90 days late
Bankruptcy probability, 12 months
14.0% High
0%0.5%1.5%4%10%≥ 25%

About 1 in 7 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,868 companies, NACE 46, micro)
Last 24 months 08-2025: 3.6%lowest value 09-2025: 3.6%● unchanged vs 08-2025lowest value 10-2025: 3.8%▲ +0.2 percentage points vs 09-2025 11-2025: 4.1%▲ +0.3 percentage points vs 10-2025 12-2025: 4.3%▲ +0.2 percentage points vs 11-2025 01-2026: 4.7%▲ +0.4 percentage points vs 12-2025 02-2026: 4.9%▲ +0.2 percentage points vs 01-2026 03-2026: 9.1%▲ +4.2 percentage points vs 02-2026 04-2026: 10.4%▲ +1.3 percentage points vs 03-2026 05-2026: 10.7%▲ +0.3 percentage points vs 04-2026 06-2026: 10.7%● unchanged vs 05-2026 07-2026: 10.7%● unchanged vs 06-2026 08-2026: 10.8%▲ +0.1 percentage points vs 07-2026 09-2026: 10.9%▲ +0.1 percentage points vs 08-2026 10-2026: 14.0%▲ +3.1 percentage points vs 09-2026highest value
Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
raises risk
raises risk · 1 financial year not filed after the legal deadline; last filed accounts filed 208 days late; 1 of the last 3 late
NBB · filings
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Figures for financial year 2024 (filed 26-02-2026)
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · 2024 accounts filed 208 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 24-02-2026, 208 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 1 filing
Deviation from the deadline
2024
208 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its 2024 accounts 208 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Resignations & appointmentsGazette deed
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Registered office · Purpose · Amendment…Name change · Registered-office move…

Key points

  • Caution: Latest accounts filed lateafter the legal deadline 208 days View
  • Positive: Among the best 5% on solvencysector median 39.3% · 15,452 companies 100.0% View
  • Controlled by TMF BELGIUM 100% View

By topic

Board & ownership

Board
2 members
Parent
TMF BELGIUM · 100%
  • Flemming WAGNERDirector
  • Pieter VAN DUIJVENBODEDirector
Go to Board & ownership

Timeline

Events
5
Since
2024
  1. 04-03-2025Resignations: Gitte DE BRABANDER (director) and Miruna…
  2. 22-07-2024Incorporation
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
18-07-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
15
Purpose
“De groothandel in farmaceutische producten, geneesmiddelen en medische hulpmiddelen, met…” (deed in Dutch)
Go to Articles of association

Key facts about PLURIPHARM BELGIUM

What is the company number of PLURIPHARM BELGIUM?
1011.718.215. In Belgium the VAT number is the company number with BE in front: BE 1011.718.215.
Where is PLURIPHARM BELGIUM based?
The registered office is at Oudebaan 61, 2610 Antwerpen.Company details
What does PLURIPHARM BELGIUM do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of PLURIPHARM BELGIUM?
Private limited company (BV).
When was PLURIPHARM BELGIUM founded?
On 18-07-2024.
Is PLURIPHARM BELGIUM still active?
Yes, PLURIPHARM BELGIUM is an active enterprise in the KBO register.
What is the turnover of PLURIPHARM BELGIUM?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Where can I find the annual accounts of PLURIPHARM BELGIUM?
PLURIPHARM BELGIUM filed 1 annual account with the National Bank of Belgium, for financial year 2024.

Companies related to PLURIPHARM BELGIUM

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.